Announced
Completed
Financials
Tags
Completed
Friendly
United States
pharmaceutical manufacturing
Pharmaceuticals
Majority
Private
Acquisition
Domestic
Single Bidder
Synopsis
Catalyst Clinical Research, a provider of specialized clinical development solutions, completed the acquisition of Genpro Research, a clinical research organization. Financial terms were not disclosed. "We are hugely enthusiastic about the addition of Genpro to our family. We share the opportunity to expand our global footprint, broaden and deepen our services, and to use the AI platform to create value for ourselves and customers in a range of labor-intensive document creation processes. In addition, our approach to prioritizing culture and treating our teams like family are similar and will act as a critical foundation for our combined company as we move forward," Nick Dyer, Catalyst CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.